Is Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Poised For Further Gains At A 19.84% Distance From The Low?
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.69. At the close of